There are extra therapies accessible for superior prostate most cancers than ever earlier than offering folks with superior prostate most cancers with extra choices and extra hope. This video discusses PSMA-targeted remedy, or lutetium Lu 177 vipivotide tetraxetan, for superior prostate most cancers. Updates are supplied by Mayo Clinic prostate most cancers consultants, Dan Childs, M.D., medical oncologist, Jacob Orme, M.D., Ph.D, medical oncologist, and Geoffrey Johnson, M.D., Ph.D., radiologist and nuclear medication specialist.
Watch the video and study extra about superior prostate most cancers and PSMA-targeted remedy at mayoclinic.com/diseases-conditions/metastatic-prostate-cancer.
For extra details about superior prostate most cancers, watch our video, About Advanced Prostate Cancer and Treatment Advancements: https://www.youtube.com/watch?v=M2k7OZsR5Z8
Chapter timestamps:
0:00 Hope for Advanced Prostate Cancer
0:22 What is Advanced Prostate Cancer
0:33 Treatment Approach for Metastatic Disease
0:52 Advanced Prostate Cancer Treatment Overview
1:06 Radiopharmaceuticals for Advanced Prostate Cancer
1:15 How lutetium Lu 177 vipivotide tetraxetan Works
2:04 Minimizing Side Effects with PSMA-targeted Therapy
2:57 Comprehensive Radiopharmaceutical Centers of Excellence
3:17 Advanced Prostate Cancer Care at Mayo Clinic
From Mayo Clinic to your inbox, sign-up at no cost: https://mayocl.in/3e71zfi
Visit Mayo Clinic: https://mayocl.in/2COVmlm
Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, previously Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
